Invenomic Capital Management LP Increases Position in Clarivate PLC $CLVT

Invenomic Capital Management LP boosted its holdings in shares of Clarivate PLC (NYSE:CLVT) by 3.8% in the 4th quarter, Holdings Channel reports. The fund owned 9,029,414 shares of the company’s stock after acquiring an additional 326,369 shares during the quarter. Clarivate accounts for 1.4% of Invenomic Capital Management LP’s holdings, making the stock its 18th largest holding. Invenomic Capital Management LP’s holdings in Clarivate were worth $30,158,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the business. Cetera Investment Advisers grew its stake in Clarivate by 11.2% during the 2nd quarter. Cetera Investment Advisers now owns 26,034 shares of the company’s stock valued at $112,000 after acquiring an additional 2,617 shares in the last quarter. California State Teachers Retirement System grew its stake in Clarivate by 0.9% during the 2nd quarter. California State Teachers Retirement System now owns 303,147 shares of the company’s stock valued at $1,304,000 after acquiring an additional 2,788 shares in the last quarter. Envestnet Asset Management Inc. grew its stake in Clarivate by 3.9% during the 3rd quarter. Envestnet Asset Management Inc. now owns 77,275 shares of the company’s stock valued at $296,000 after acquiring an additional 2,884 shares in the last quarter. IFP Advisors Inc grew its stake in Clarivate by 8.1% during the 3rd quarter. IFP Advisors Inc now owns 41,426 shares of the company’s stock valued at $170,000 after acquiring an additional 3,117 shares in the last quarter. Finally, Hsbc Holdings PLC grew its stake in Clarivate by 4.3% during the 2nd quarter. Hsbc Holdings PLC now owns 116,648 shares of the company’s stock valued at $500,000 after acquiring an additional 4,792 shares in the last quarter. Hedge funds and other institutional investors own 85.72% of the company’s stock.

Analyst Ratings Changes

CLVT has been the subject of several research reports. Barclays dropped their price objective on shares of Clarivate from $4.00 to $2.40 and set an “underweight” rating for the company in a research note on Wednesday, February 25th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Clarivate in a research note on Friday, March 27th. Citigroup dropped their price objective on shares of Clarivate from $4.25 to $2.80 and set a “neutral” rating for the company in a research note on Wednesday, March 4th. Wall Street Zen raised shares of Clarivate from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Finally, Royal Bank Of Canada decreased their target price on shares of Clarivate from $5.00 to $3.00 and set a “sector perform” rating on the stock in a report on Wednesday, February 25th. Five investment analysts have rated the stock with a Hold rating and three have issued a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Reduce” and an average target price of $3.22.

Clarivate Stock Performance

Shares of CLVT stock opened at $2.07 on Thursday. The firm’s 50 day moving average price is $2.49 and its 200-day moving average price is $2.70. The company has a debt-to-equity ratio of 0.89, a quick ratio of 0.84 and a current ratio of 0.84. Clarivate PLC has a one year low of $1.66 and a one year high of $4.77. The firm has a market cap of $1.32 billion, a P/E ratio of -9.83 and a beta of 1.36.

Clarivate (NYSE:CLVT) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.18 EPS for the quarter, topping the consensus estimate of $0.14 by $0.04. Clarivate had a negative net margin of 5.61% and a positive return on equity of 8.82%. The firm had revenue of $585.50 million for the quarter, compared to analyst estimates of $569.50 million. During the same period in the prior year, the business posted $0.14 EPS. The business’s revenue for the quarter was down 1.4% compared to the same quarter last year. Clarivate has set its FY 2026 guidance at 0.700-0.800 EPS. As a group, equities research analysts predict that Clarivate PLC will post 0.65 EPS for the current year.

Clarivate Company Profile

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.